way 100135 has been researched along with venlafaxine hydrochloride in 1 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (venlafaxine hydrochloride) | Trials (venlafaxine hydrochloride) | Recent Studies (post-2010) (venlafaxine hydrochloride) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 2,846 | 686 | 1,136 |
| Protein | Taxonomy | way 100135 (IC50) | venlafaxine hydrochloride (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.9466 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.18 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.55 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bal, R; Yaman, B | 1 |
1 other study(ies) available for way 100135 and venlafaxine hydrochloride
| Article | Year |
|---|---|
Pindolol potentiates the antidepressant effect of venlafaxine by inhibiting 5-HT1A receptor in DRN neurons of mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Dorsal Raphe Nucleus; Drug Synergism; Mice; Mice, Inbred BALB C; Motor Activity; Pindolol; Piperazines; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Venlafaxine Hydrochloride | 2022 |